# OnCo record mipi (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/mipi/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "mipi" ;
  schema:name "MIPI (Mantle Cell Lymphoma International Prognostic Index)"@en ;
  schema:alternateName "MIPI"@en, "MIPI-c"@en, "MIPI-b"@en, "combined MIPI"@en, "biological MIPI"@en, "Mantle Cell Lymphoma International Prognostic Index"@en, "high-risk mantle cell lymphoma"@en, "blastoid mantle cell lymphoma"@en, "blastoid variant"@en, "pleomorphic mantle cell lymphoma"@en ;
  schema:description "MIPI turns age, performance status, LDH and white cell count into a low, intermediate or high-risk label for mantle cell lymphoma, and adding Ki-67 (MIPI-c) or TP53 status sharpens it; high-risk and TP53-mutated disease is where chemotherapy alone fails and BTK inhibitors, CAR-T and trials come in first."@en ;
  schema:url <https://onco.cc/terms/mipi/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:related <https://onco.cc/terms/ipi-score/>, <https://onco.cc/terms/cyclin-d1-t11-14/>, <https://onco.cc/terms/tp53-mutated/>, <https://onco.cc/terms/proliferation/>, <https://onco.cc/terms/cytogenetics/>, <https://onco.cc/drugs/ibrutinib/>, <https://onco.cc/drugs/acalabrutinib/>, <https://onco.cc/drugs/zanubrutinib/>, <https://onco.cc/drugs/pirtobrutinib/>, <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/rituximab/> ;
  onco:cancers <https://onco.cc/cancers/mantle-cell-lymphoma/> .